128 related articles for article (PubMed ID: 6344178)
1. Antithrombin III concentrates in intensive care.
Bernhardt W; Nováková-Banet A
Ric Clin Lab; 1983; 13(1):61-6. PubMed ID: 6344178
[TBL] [Abstract][Full Text] [Related]
2. [Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].
Takahashi K
Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):889-97. PubMed ID: 6940410
[No Abstract] [Full Text] [Related]
3. [Perioperative management for transurethral resection of bladder tumor (TUR-Bt) associated with congenital antithrombin III deficiency].
Mizuno J; Kato S; Namai S; Komiya Y; Kuwana Y; Morita S
Masui; 2009 Dec; 58(12):1524-7. PubMed ID: 20055199
[TBL] [Abstract][Full Text] [Related]
4. Peroperative effects of fresh frozen plasma and antithrombin III on heparin sensitivity and coagulation during nitroglycerine infusion in coronary artery bypass surgery.
Kanbak M; Oc B; Salman MA; Ocal T; Oc M
Blood Coagul Fibrinolysis; 2011 Oct; 22(7):593-9. PubMed ID: 21799398
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation.
Fourrier F; Chopin C; Huart JJ; Runge I; Caron C; Goudemand J
Chest; 1993 Sep; 104(3):882-8. PubMed ID: 8365305
[TBL] [Abstract][Full Text] [Related]
6. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
[TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
8. Effects of a combined antithrombin III and protein C supplementation in porcine acute endotoxic shock.
Fourrier F; Jourdain M; Tournoys A; Gosset P; Mangalaboyi J; Chopin C
Shock; 1998 Nov; 10(5):364-70. PubMed ID: 9840653
[TBL] [Abstract][Full Text] [Related]
9. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
Okajima K
Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
[TBL] [Abstract][Full Text] [Related]
10. [Antithrombin III substitution in dialysis-dependent renal insufficiency].
Schrader J; Köstering H; Kramer P; Scheler F
Dtsch Med Wochenschr; 1982 Dec; 107(48):1847-50. PubMed ID: 7140568
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA
Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072
[TBL] [Abstract][Full Text] [Related]
12. [An experimental study on the protective effect of ATIII against acute disseminated intravascular coagulation].
Takei H
Nihon Ketsueki Gakkai Zasshi; 1986 Aug; 49(5):1081-90. PubMed ID: 3788435
[No Abstract] [Full Text] [Related]
13. Antithrombin III in patients admitted to intensive care units: a multicenter observational study.
Messori A; Vacca F; Vaiani M; Trippoli S;
Crit Care; 2002 Oct; 6(5):447-51. PubMed ID: 12398786
[TBL] [Abstract][Full Text] [Related]
14. Antithrombin III supplementation on extracorporeal membrane oxygenation: impact on heparin dose and circuit life.
Byrnes JW; Swearingen CJ; Prodhan P; Fiser R; Dyamenahalli U
ASAIO J; 2014; 60(1):57-62. PubMed ID: 24296776
[TBL] [Abstract][Full Text] [Related]
15. Influence of antithrombin III on coagulation and inflammation in porcine septic shock.
Dickneite G; Leithäuser B
Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1566-72. PubMed ID: 10364091
[TBL] [Abstract][Full Text] [Related]
16. Revisiting antithrombin in health and disease, congenital deficiencies and genetic variants, and laboratory studies on α and β forms.
Amiral J; Seghatchian J
Transfus Apher Sci; 2018 Apr; 57(2):291-297. PubMed ID: 29784539
[TBL] [Abstract][Full Text] [Related]
17. [Antithrombin III. Physiologic, physiopathologic and laboratory aspects].
de Sousa JC; Ferreira R; Carriço F; Nunes V; Geraldes MJ; Parreira F; Ribeiro C
Rev Port Cardiol; 1991 Sep; 10(9):693-9. PubMed ID: 1747261
[TBL] [Abstract][Full Text] [Related]
18. Neonatal antithrombin III deficiency.
Manco-Johnson MJ
Am J Med; 1989 Sep; 87(3B):49S-52S. PubMed ID: 2679071
[TBL] [Abstract][Full Text] [Related]
19. Antithrombin III patterns in disseminated intravascular coagulation.
Bick RL; Bick MD; Fekete LF
Am J Clin Pathol; 1980 Apr; 73(4):577-83. PubMed ID: 7369182
[TBL] [Abstract][Full Text] [Related]
20. Disseminated intravascular coagulation with multiple arterial thromboses responding to antithrombin-III concentrate infusion.
Wisecarver JL; Haire WD
Thromb Res; 1989 Jun; 54(6):709-17. PubMed ID: 2781511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
